ClinicalTrials.Veeva

Menu

A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer

Memorial Sloan Kettering Cancer Center (MSK) logo

Memorial Sloan Kettering Cancer Center (MSK)

Status

Active, not recruiting

Conditions

Prostate Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to see if a telemedicine group doctor's appointment is a practical (feasible) and acceptable method for following people with prostate cancer being managed with active surveillance when compared with the usual approach of individual telemedicine visits, which involve the participant visiting a doctor on their own. The researchers will compare the telemedicine group and individual visits by measuring on participant satisfaction and quality of life in each type of visit. Telemedicine is the use of secure video technology on a desktop computer, laptop, smartphone, or tablet to provide and receive healthcare from a distance.

Enrollment

88 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A scheduled appointment for a subsequent Active Surveillance (AS) follow-up visit for management of localized prostate cancer
  • Biopsy Gleason score 3+3=6 (Grade Group 1) or biopsy Gleason score 3+4=7 (Grade Group 2)
  • Clinical T stage ≤T2B
  • Access to a device with Zoom
  • Ability to speak and understand English

Exclusion criteria

  • Plan to undergo a prostate biopsy at this follow-up visit

Trial design

88 participants in 2 patient groups

Shared Medical Appointments
Usual Care Appointments

Trial contacts and locations

1

Loading...

Central trial contact

Sigrid Carlsson, MD, PhD, MPH; Behfar Ehdaie, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems